Date | Upside/Downside | Analyst Firm | Price Target Change | Rating Change | Previous / Current Rating |
---|---|---|---|---|---|
11/09/2023 | -4.19% | Jefferies | $22 → $16 | Downgrades | Buy → Hold |
11/01/2023 | 1.8% | TD Cowen | → $17 | Initiates Coverage On | → Market Perform |
10/26/2023 | 1.8% | Citigroup | $18 → $17 | Maintains | Neutral |
10/26/2023 | -4.19% | Stephens & Co. | $20 → $16 | Maintains | Equal-Weight |
10/17/2023 | 7.78% | JP Morgan | $19.5 → $18 | Maintains | Underweight |
10/06/2023 | 7.78% | Citigroup | $19 → $18 | Maintains | Neutral |
10/03/2023 | 1.8% | Morgan Stanley | $18 → $17 | Maintains | Equal-Weight |
08/01/2023 | 7.78% | Compass Point | $19 → $18 | Maintains | Neutral |
07/27/2023 | 19.76% | Keefe, Bruyette & Woods | $18 → $20 | Maintains | Market Perform |
07/27/2023 | 7.78% | Morgan Stanley | $18 → $18 | Reiterates | Equal-Weight → Equal-Weight |
07/13/2023 | 7.78% | Morgan Stanley | $17 → $18 | Maintains | Equal-Weight |
07/11/2023 | 13.77% | Compass Point | $16 → $19 | Maintains | Neutral |
07/10/2023 | 13.77% | Citigroup | $17 → $19 | Maintains | Neutral |
04/27/2023 | 19.76% | Stephens & Co. | → $20 | Reiterates | → Equal-Weight |
04/27/2023 | -1.2% | Credit Suisse | → $16.5 | Reiterates | → Neutral |
04/18/2023 | 1.8% | Citigroup | $19 → $17 | Maintains | Neutral |
04/17/2023 | -4.19% | JP Morgan | $18 → $16 | Maintains | Underweight |
04/11/2023 | 7.78% | Keefe, Bruyette & Woods | $19 → $18 | Maintains | Market Perform |
04/05/2023 | 1.8% | Morgan Stanley | $19 → $17 | Maintains | Equal-Weight |
02/01/2023 | 13.77% | Citigroup | $15 → $19 | Maintains | Neutral |
01/26/2023 | -1.2% | Credit Suisse | $14 → $16.5 | Maintains | Neutral |
01/26/2023 | 13.77% | BMO Capital | $17 → $19 | Maintains | Market Perform |
12/01/2022 | -4.19% | Morgan Stanley | $14 → $16 | Upgrades | Underweight → Equal-Weight |
10/27/2022 | -16.17% | Morgan Stanley | $14.5 → $14 | Maintains | Underweight |
10/07/2022 | -13.17% | Morgan Stanley | → $14.5 | Initiates Coverage On | → Underweight |
09/09/2022 | -22.16% | Barclays | $19 → $13 | Downgrades | Overweight → Equal-Weight |
07/11/2022 | 7.78% | Barclays | $25 → $18 | Maintains | Overweight |
04/11/2022 | 1.8% | JP Morgan | → $17 | Downgrades | Neutral → Underweight |
03/31/2022 | 7.78% | Compass Point | → $18 | Downgrades | Buy → Neutral |
01/27/2022 | 7.78% | Credit Suisse | $20 → $18 | Maintains | Neutral |
01/27/2022 | 25.75% | JP Morgan | $23 → $21 | Maintains | Neutral |
01/03/2022 | — | Stephens & Co. | Downgrades | Overweight → Equal-Weight | |
09/30/2021 | — | Seaport Global | Initiates Coverage On | → Neutral | |
07/29/2021 | 31.74% | Stephens & Co. | $18 → $22 | Maintains | Overweight |
07/29/2021 | 25.75% | Citigroup | $19 → $21 | Downgrades | Buy → Neutral |
07/09/2021 | 37.72% | Barclays | $20 → $23 | Maintains | Overweight |
07/06/2021 | 19.76% | Keefe, Bruyette & Woods | $19 → $20 | Downgrades | Outperform → Market Perform |
04/29/2021 | -7.19% | Credit Suisse | $13.5 → $15.5 | Maintains | Neutral |
03/19/2021 | 13.77% | Jefferies | $11.5 → $19 | Upgrades | Hold → Buy |
01/19/2021 | -25.15% | JP Morgan | → $12.5 | Downgrades | Overweight → Neutral |
10/22/2020 | -28.14% | Wedbush | → $12 | Upgrades | Neutral → Outperform |
05/20/2020 | -40.12% | Wedbush | $18 → $10 | Maintains | Neutral |
04/09/2020 | -28.14% | Stephens & Co. | $17 → $12 | Upgrades | Equal-Weight → Overweight |
03/17/2020 | -34.13% | Barclays | → $11 | Upgrades | Equal-Weight → Overweight |
01/23/2020 | 7.78% | Wedbush | $15 → $18 | Maintains | Neutral |
01/09/2020 | -4.19% | Barclays | → $16 | Downgrades | Overweight → Equal-Weight |
12/11/2019 | 1.8% | Stephens & Co. | → $17 | Initiates Coverage On | → Equal-Weight |
10/28/2019 | -10.18% | Wedbush | $15.75 → $15 | Maintains | Neutral |
10/24/2019 | 7.78% | BMO Capital | $17 → $18 | Maintains | Market Perform |
07/25/2019 | 1.8% | Barclays | $14 → $17 | Maintains | Overweight |
07/25/2019 | — | Wedbush | Downgrades | Outperform → Neutral | |
07/25/2019 | — | Credit Suisse | Downgrades | Outperform → Neutral | |
04/25/2019 | -4.19% | BMO Capital | $14 → $16 | Maintains | Market Perform |
04/25/2019 | -13.17% | JP Morgan | $12.5 → $14.5 | Upgrades | Neutral → Overweight |
01/16/2019 | -28.14% | JP Morgan | $13 → $12 | Upgrades | Underweight → Neutral |
What is the target price for Navient (NAVI)?
The latest price target for Navient (NASDAQ: NAVI) was reported by Jefferies on November 9, 2023. The analyst firm set a price target for $16.00 expecting NAVI to fall to within 12 months (a possible -4.19% downside). 23 analyst firms have reported ratings in the last year.
What is the most recent analyst rating for Navient (NAVI)?
The latest analyst rating for Navient (NASDAQ: NAVI) was provided by Jefferies, and Navient downgraded their hold rating.
When is the next analyst rating going to be posted or updated for Navient (NAVI)?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Navient, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Navient was filed on November 9, 2023 so you should expect the next rating to be made available sometime around November 9, 2024.
Is the Analyst Rating Navient (NAVI) correct?
While ratings are subjective and will change, the latest Navient (NAVI) rating was a downgraded with a price target of $22.00 to $16.00. The current price Navient (NAVI) is trading at is $16.70, which is out of the analyst's predicted range.